DrugPatentWatch Database Preview
PENTAMIDINE ISETHIONATE Drug Profile
see a sample report or, see our see our flat-rate plans
When do Pentamidine Isethionate patents expire, and what generic alternatives are available?
The generic ingredient in PENTAMIDINE ISETHIONATE is pentamidine isethionate. There are fourteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the pentamidine isethionate profile page.
Summary for PENTAMIDINE ISETHIONATE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 70 |
| Clinical Trials: | 1 |
| Patent Applications: | 829 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | PENTAMIDINE ISETHIONATE at DailyMed |
Medical Subject Heading (MeSH) Categories for PENTAMIDINE ISETHIONATE
Synonyms for PENTAMIDINE ISETHIONATE
| [pentane-1,5-diylbis(oxy-4,1-phenylene)]bis(aminomethaniminium) bis(2-hydroxyethanesulfonate) |
| 1,5-Bis(p-amidinophenoxy)pentane bis(2-hydroxyethanesulfonate salt) |
| 1,5-bis[p-amidinophenoxy]pentane bis[2-hydroxyethanesulfonate salt] isethionate salt |
| 140-64-7 |
| 140P647 |
| 2512 R.P. |
| 4-[5-(4-amidinophenoxy)pentyloxy]benzenecarboxamidine, 2-hydroxyethanesulfonic acid, 2-hydroxyethanesulfonic acid |
| 4-[5-(4-carbamimidoylphenoxy)pentoxy]benzenecarboximidamide;2-hydroxyethanesulfonic acid |
| 4,4 inverted exclamation marka-(Pentamethylenedioxy)dibenzamidine bis(2-hydroxyethanesulfonate) |
| 4,4'-(Pentamethylenedioxy)-dibenzamidine bis(2-hydroxyethanesulfonate) |
| 4,4'-(pentamethylenedioxy)dibenzamide bis(2-hydroxyethanesulfonate) |
| 4,4'-(Pentamethylenedioxy)dibenzamidine bis-2-hydroxyethanesulfonate salt |
| 4,4'-(pentamethylenedioxy)dibenzamidine bis(2-hyd |
| 4,4'-(Pentamethylenedioxy)dibenzamidine bis(2-hydroxyethanesulfonate) |
| 4,4'-(pentamethylenedioxy)dibenzamidine, bis-2-hydroxyethanesulfonate |
| 4,4'-(pentane-1,5-diylbis(oxy))dibenzimidamide bis(2-hydroxyethane-1-sulfonate) |
| 4,4'-(Pentane-1,5-diylbis(oxy))dibenzimidamide bis(2-hydroxyethanesulfonate) |
| 4,4'-(Pentane-1,5-diylbis(oxy))dibenzimidamide bis(2-hydroxyethanesulfonate);4,4'-(Pentane-1,5-diylbis(oxy))dibenzimidamide bis(2-hydroxyethanesulfonate) |
| 4,4'-[pentane-1,5-diylbis(oxy)]dibenzenecarboximidamide bis(2-hydroxyethanesulfonic acid) |
| 4,4'-[pentane-1,5-diylbis(oxy)]dibenzenecarboximidamide bis(2-hydroxyethylsulfonate) |
| 4,4'-diamidino-a,w-diphenoxypentane isethionate |
| 4,4'-Diamidino-alpha,omega-diphenoxypentane isethionate |
| 4,4'-Diamidinodiphenoxypentane di(beta-hydroxyethanesulfonate) |
| 4CH-018037 |
| AB0015398 |
| AC1L1RR1 |
| AC1Q6X9Y |
| AK-51766 |
| AKOS015914189 |
| ANW-48586 |
| API0003784 |
| AX8027505 |
| BC221820 |
| Benzamidine, 4,4'-(pentamethylenedioxy)di-, bis(beta-hydroxyethanesulfonate) |
| bis(2-hydroxyethane-1-sulfonic acid); 4-{[5-(4-carbamimidoylphenoxy)pentyl]oxy}benzene-1-carboximidamide |
| BR-51766 |
| C-23299 |
| C23H36N4O10S2 |
| CAS-140-64-7 |
| CCG-39715 |
| CCRIS 1660 |
| CHEBI:7977 |
| CHEMBL361506 |
| CS-4133 |
| CTK8B5397 |
| D00834 |
| DSSTox_CID_3796 |
| DSSTox_GSID_23796 |
| DSSTox_RID_77194 |
| DTXSID5023796 |
| EINECS 205-424-1 |
| Ethanesulfonic acid, 2-hydroxy-, compd. with 4,4'-(1,5-pentanediylbis(oxy))bis(benzenecarboximidamide) (2:1) |
| FT-0631814 |
| HMS1569P07 |
| HMS1921M19 |
| HMS2096P07 |
| HMS501D11 |
| HY-B0537B |
| I14-45109 |
| KS-00000Z9I |
| KS-5289 |
| Lomidine |
| M808 |
| MCULE-6357662093 |
| MFCD00079213 |
| MolPort-003-665-497 |
| NCGC00017022-01 |
| NCGC00017022-02 |
| NCGC00017022-03 |
| NCGC00017022-04 |
| NCGC00017022-05 |
| NCGC00091927-01 |
| NCGC00091927-02 |
| NCGC00091927-03 |
| NCGC00091927-04 |
| NCGC00179034-07 |
| NCGC00254121-01 |
| NCGC00259271-01 |
| Nebupent |
| OR008871 |
| p,p'-(Pentamethylenedioxy)dibenzamidine bis(beta-hydroxyethanesulfonate) |
| Pentacarinat |
| PENTAM |
| Pentam 300 |
| Pentam 300 (TN) |
| Pentamidin-Isethionat |
| Pentamidine (isethionate) |
| Pentamidine diisethionate |
| Pentamidine diisetionate |
| Pentamidine diisetionate, European Pharmacopoeia (EP) Reference Standard |
| Pentamidine isethionate (USAN) |
| Pentamidine isethionate [USAN:USP] |
| Pentamidine isethionate salt |
| Pentamidine isethionate salt, powder |
| Pentamidine isethionate, United States Pharmacopeia (USP) Reference Standard |
| Pentamidine isetionate |
| Pentamidine isetionate (JAN) |
| PENTAMIDINE; BIS(SODIUM ISETHIONATE) |
| Pentaminide isetionate |
| Pneumopent |
| Prestwick_857 |
| PubChem20964 |
| S-3112 |
| SCHEMBL33615 |
| SPECTRUM1500641 |
| SR-01000075174 |
| SR-01000075174-1 |
| ST2407516 |
| ST51006692 |
| TC-137331 |
| Tox21_110742 |
| Tox21_110742_1 |
| Tox21_201722 |
| Tox21_300312 |
| UNII-V2P3K60DA2 |
| USAF XR-10 |
| V2P3K60DA2 |
| W-108199 |
| Z1558572531 |
US Patents and Regulatory Information for PENTAMIDINE ISETHIONATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | PENTAMIDINE ISETHIONATE | pentamidine isethionate | INJECTABLE;INJECTION | 073617-001 | Dec 18, 1995 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Watson Labs | PENTAMIDINE ISETHIONATE | pentamidine isethionate | INJECTABLE;INJECTION | 074303-001 | Aug 17, 1995 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Hospira | PENTAMIDINE ISETHIONATE | pentamidine isethionate | INJECTABLE;INJECTION | 073479-001 | Jun 30, 1992 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Seton Pharms | PENTAMIDINE ISETHIONATE | pentamidine isethionate | INJECTABLE;INJECTION | 206666-001 | Sep 28, 2017 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
